Insider Transactions in Q1 2025 at Health Catalyst, Inc. (HCAT)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 03
2025
|
Daniel D. Burton Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
33,677
-2.25%
|
$134,708
$4.58 P/Share
|
|
Mar 03
2025
|
Linda Llewelyn Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,525
-4.52%
|
$30,100
$4.58 P/Share
|
|
Mar 03
2025
|
Kevin Lee Freeman Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,800
-2.73%
|
$43,200
$4.58 P/Share
|
|
Mar 03
2025
|
Jason Alger Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,304
-2.61%
|
$29,216
$4.58 P/Share
|
|
Mar 03
2025
|
Benjamin Landry General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
9,024
-4.92%
|
$36,096
$4.58 P/Share
|
|
Mar 03
2025
|
Daniel Le Sueur Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,232
-3.81%
|
$36,928
$4.58 P/Share
|
|
Mar 01
2025
|
Duncan Gallagher |
BUY
Grant, award, or other acquisition
|
Direct |
3,033
+3.99%
|
-
|
|
Mar 01
2025
|
Julie Larson Green |
BUY
Grant, award, or other acquisition
|
Direct |
2,450
+3.32%
|
-
|
|
Feb 20
2025
|
Benjamin Landry General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
111,038
+21.68%
|
-
|
|
Feb 20
2025
|
Jason Alger Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
192,950
+22.22%
|
-
|
|
Feb 20
2025
|
Kevin Lee Freeman Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
158,262
+15.75%
|
-
|
|
Feb 20
2025
|
Daniel D. Burton Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
371,437
+11.0%
|
-
|
|
Feb 20
2025
|
Daniel Le Sueur Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
156,340
+21.51%
|
-
|
|
Feb 20
2025
|
Linda Llewelyn Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
80,750
+18.71%
|
-
|
|
Feb 18
2025
|
Linda Llewelyn Chief People Officer |
SELL
Open market or private sale
|
Direct |
6,441
-6.98%
|
$32,205
$5.43 P/Share
|
|
Feb 05
2025
|
Daniel Le Sueur Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,209
-5.71%
|
$26,045
$5.76 P/Share
|
|
Jan 15
2025
|
Linda Llewelyn Chief People Officer |
SELL
Open market or private sale
|
Direct |
6,442
-6.53%
|
$32,210
$5.8 P/Share
|
|
Jan 06
2025
|
Benjamin Landry General Counsel |
SELL
Open market or private sale
|
Direct |
2,500
-3.34%
|
$17,500
$7.52 P/Share
|
|
Jan 06
2025
|
Daniel Le Sueur Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,209
-5.4%
|
$36,463
$7.51 P/Share
|